PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 29372592-0 2018 Rasagiline delays retinal degeneration in a mouse model of retinitis pigmentosa via modulation of Bax/Bcl-2 expression. rasagiline 0-10 B cell leukemia/lymphoma 2 Mus musculus 102-107 29372592-4 2018 Rasagiline is an antiparkinsonian drug that has shown neuroprotective effects in part attributed to a modulation of Bax/Bcl-2 expression. rasagiline 0-10 B cell leukemia/lymphoma 2 Mus musculus 120-125 29372592-9 2018 In addition, the expression of proapoptotic Bax decreased, whereas the antiapoptotic factor Bcl-2 increased after rasagiline treatment. rasagiline 114-124 B cell leukemia/lymphoma 2 Mus musculus 92-97 26142126-5 2015 Furthermore, we found that rasagiline upregulated expression levels of the synaptic plasticity markers brain-derived neurotrophic factor, tyrosine kinase-B receptor, and synapsin-1, increased Bcl-2 to Bax antiapoptotic ratio and the activity of the antioxidant enzyme, catalase in brain of aged mice. rasagiline 27-37 B cell leukemia/lymphoma 2 Mus musculus 192-197